Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Orthocell Posts Strongest US Remplir Sales Month Since Launch

OCC: $0.570 +3.64% · MC: $155M

Orthocell sold 92 units of its Remplir nerve repair product in the US in October, generating $279,000 in revenue. Unit sales rose 84% from the monthly average in the first quarter of FY27. The company attributed the result to growing surgeon adoption, repeat use, a broader distributor network and expanded hospital access.

Source announcements: 2026-11-02 08:32 to 2026-11-02 08:32 Sydney time
Story updated 2026-11-02 10:24 Sydney time
SourcesStrongest U.S. Remplir Sales Month Since Launch
Comments